Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › MPL mutations in JAK2 V617F negative patients with myeloproliferative disease

MPL mutations in JAK2 V617F negative patients with myeloproliferative disease

US Patent 10782299 · Granted Sep 22, 2020

Estimated economic value: $53,068,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for detecting mutations in JAK2 nucleic acid2025
Compositions and methods for detecting mutations in JAK2 nucleic acid2025
EML4-ALK translocations in lung cancer2025
BCR-ABL variants2024
Hematopoietic cell phenotyping using circulating cell-free markers2023
EML4-ALK translocations in lung cancer2023
Circulating microRNA as a marker for hepatocellular carcinoma2022
BCR-ABL truncation mutations2022
BCR-ABL truncation mutations2022
BCR-ABL variants2022
BCR-ABL1 splice variants and uses thereof2021
Methods for detecting gene dysregulation by intragenic differential expression2021